Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering
International Journal of Cancer · 2024
DOI: 10.1002/ijc.35055 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Cancer, 2024. Verfasst von Mona Alharbi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, University of Queensland Centre for Clinical Research, Faculty of Medici…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Extracellular Vesicles. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Medical Research Future Fund, Ovarian Cancer Research Foundation, The Donald & Joan Wilson Foundation Ltd.
Abstract (Originalsprache)
Extracellular vesicles (EVs) function as natural mediators of intercellular communication, secreted by cells to facilitate cell–cell signaling. Due to their low toxicity, immunogenicity, biodegradability, and potential to encapsulate therapeutic drugs, EVs hold significant therapeutic promise. Nevertheless, their limited targeting ability often diminishes their therapeutic impact. Therefore, enhancing EVs by incorporating targeting units onto their membranes could bolster their targeting capabilities, enabling them to accumulate in specific cells and tissues. In this study, we engineered EVs to fuse ephrin‐B2 with the EV membrane protein LAMP2b. This modification aimed to direct the engineered EVs toward the ephrin‐B4 receptor expressed on the surface of ovarian cancer cells. The engineered EVs retained their inherent properties, including size, expression of EV membrane proteins, and morphology, upon isolation. In vitro experiments using real‐time imaging revealed that EVs engineered with the ephrin‐B2 ligand exhibited substantial internalization and uptake by ovarian cancer cells, in stark contrast to native EVs. In vivo, the engineered EVs carrying the ephrin‐B2 ligand effectively targeted ovarian cancer cells, surpassing the targeting efficiency of control EVs. This innovative approach establishes a novel targeting system, enhancing the uptake of EVs by ovarian cancer cells. Our findings underscore the potential of using EVs to target cancer cells, thereby enhancing the effectiveness of anti‐cancer therapies while minimizing off‐target effects and toxicity in normal cells and organs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, University of Queensland Centre for Clinical Research, Faculty of Medicine, Royal Brisbane and Women's Hospital, The University of Queensland,…
- Department of Biochemistry, College of Science, King Saud University, Riyadh, Saudi Arabia.
- UQ Centre for Extracellular Vesicle Nanomedicine, The University of Queensland, Brisbane, QLD, Australia.
- Department of Clinical Biochemistry and Immunology, Faculty of Pharmacy, University of Concepción, Concepción, Chile.
- Centre for Clinical Research, Royal Brisbane and Women's Hospital, The University of Queensland, Brisbane, Australia.
- School of Biomedical Sciences, The University of Queensland, Brisbane, Australia.
ORCID-Profile: Carlos Salomon
Förderung
- The Medical Research Future Fund
- Ovarian Cancer Research Foundation
- The Donald & Joan Wilson Foundation Ltd
- National Health and Medical Research Council
- Lion Medical Research Foundation
Zitieren
APA
Alharbi, M., Lai, A., Godbole, N., Guanzon, D., Nair, S., Zuñiga, F., Quinn, A., Yang, M., Wu, S. Y., & Salomon, C. (2024). Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering. International Journal of Cancer. https://doi.org/10.1002/ijc.35055
Vancouver
Alharbi M, Lai A, Godbole N, Guanzon D, Nair S, Zuñiga F, et al. Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering. International Journal of Cancer. 2024. doi:10.1002/ijc.35055
BibTeX
@article{Alharbi2024,
author = {Alharbi, Mona and Lai, Andrew and Godbole, Nihar and Guanzon, Dominic and Nair, Soumyalekshmi and Zuñiga, Felipe and Quinn, Alexander and Yang, Mengliu and Wu, Sherry Y and Salomon, Carlos},
title = {Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering},
journal = {International Journal of Cancer},
year = {2024},
doi = {10.1002/ijc.35055}
}
EUVIMED